Cellular Pathology, Digital Pathology and AI
Source BioScience provides an end-to-end clinical healthcare service from histopathology, including digital pathology and AI, through to molecular diagnostics services; bringing a unique clinical workflow for the delivery of precision therapeutics.
Source LDPath, a part of Source BioScience, has built a significant and growing network of specialist consultant pathologists, all registered with the Royal College of Pathologists and General Medical
Council. We offer industry leading pathology services with a focus on digital pathology and AI.
• Wet surgical specimens
• Pre-prepared blocks or slides
Our expertise in histopathology, coupled with the latest technologies in molecular diagnostics, enables
us to provide a comprehensive service to support your requirement for specialised diagnostics.
• Mutational Analysis (e.g KRAS/BRAF/EGFR)
• NGS gene panel targeted sequencing
• Personalised Medicine (e.g ToxNav, EndoPredict)
• Hormone Receptor Testing
• Routine and Specialist Immunohistochemistry Assays (IHC)
• In-situ Hybridisation (ISH)
• Circulating Tumour cell assessment (CTC)
• Methylation Analysis - MLH1 promoter hypermethylation
For more information on all of our services download here.